Takeaways: Skyrizi’s pediatric approval expands AbbVie’s reach in plaque psoriasis by extending its IL-23 inhibitor franchise to children and adolescents in Canada. High rates of skin clearance ...
Takeaways: Slenyto gives Canadian clinicians a prescription, extended‑release melatonin specifically studied for children and teens (ages 2 to <18) with autism spectrum disorder and/or Smith‑Mageni...
